Evidence map›Paper›PMID 36329942›Full record

ArticleRSC advances2022

The

Ruiming Xiao, Hongzhang Chen, Hongbei Han, Guangjuan Luo, Ying Lin

Abstract read
In one paragraph

Article in RSC advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ruiming XiaoSouth China University of Technology, School of Bio and Chemical Engineering, Guangdong Key Laboratory of Fermentation and Enzyme Engineering Guangzhou 510006 People's Republic of China feylin@scut.edu.cn.ORCID https://orcid.org/0000-0002-0862-5940
Hongzhang ChenSouth China University of Technology, School of Bio and Chemical Engineering, Guangdong Key Laboratory of Fermentation and Enzyme Engineering Guangzhou 510006 People's Republic of China feylin@scut.edu.cn.
Hongbei HanSouth China University of Technology, School of Bio and Chemical Engineering, Guangdong Key Laboratory of Fermentation and Enzyme Engineering Guangzhou 510006 People's Republic of China feylin@scut.edu.cn.
Guangjuan LuoSouth China University of Technology, School of Bio and Chemical Engineering, Guangdong Key Laboratory of Fermentation and Enzyme Engineering Guangzhou 510006 People's Republic of China feylin@scut.edu.cn.
Ying LinSouth China University of Technology, School of Bio and Chemical Engineering, Guangdong Key Laboratory of Fermentation and Enzyme Engineering Guangzhou 510006 People's Republic of China feylin@scut.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Compound oral liquid (COL), made from functional herbal foods, has gained immense popularity in China for healthcare. However, the interaction between the nutrients in COL and gut microbiota is still unclear. In our study, the content of total flavonoids, polyphenols, and proteins was increased and the total sugar reduced by crushing raw ingredients to 10 mesh (COL-C). After 24 h incubation with supplemented COL by human gut microbiota, the results of 16S rRNA high-throughput sequencing revealed that

Identifiers

PMID36329942
PMCPMC9585530

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.